Psyence Group Inc. (CSE:PSYG)

Canada flag Canada · Delayed Price · Currency is CAD
0.1400
-0.0850 (-37.78%)
Apr 25, 2025, 3:44 PM EDT
-68.89%
Market Cap 1.31M
Revenue (ttm) n/a
Net Income (ttm) -65.83M
Shares Out 9.36M
EPS (ttm) -7.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,813
Average Volume 4,322
Open 0.1100
Previous Close 0.2250
Day's Range 0.1050 - 0.1400
52-Week Range 0.1050 - 0.5250
Beta 1.30
RSI 38.25
Earnings Date Jul 30, 2025

About Psyence Group

Psyence Group Inc., a life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom. It operates in two segments: Clinical Trial Activities and Non-Clinical Trial Activities. The company natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in... [Read more]

Sector Healthcare
Founded 2019
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PSYG
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.